Jennifer has over twenty years of legal experience in a wide range of intellectual property matters. Practicing with law firms ranging from AmLaw100 general practice firms to intellectual property boutiques, Jennifer has counseled clients ranging from individual inventors to Fortune 500 corporations. In addition to the preparation and prosecution of patent applications, Jennifer also has broad experience with managing worldwide patent portfolios, landscape analyses, patentability analyses, freedom-to-operate analyses, opinion drafting, and negotiating and drafting patent licenses and related agreements.
Jennifer has also served as Senior Director, Assistant General Counsel at a long-standing biotechnology company, where she focused on genetic engineering. Jennifer advised stakeholders from the CEO and CFO through scientific researchers and marketing professionals regarding patents, trademarks, copyrights, intellectual property licensing, sponsored research agreements, material transfer agreements, and other legal matters. Jennifer assisted in directing Research and Development planning and activities, with a view toward patentability, freedom-to-operate, scientific feasibility, market acceptance, and return on investment.
Jennifer also has broad experience in patent adversarial proceedings. For example, Jennifer was second chair on a team that successfully defended the validity and enforceability of certain key patent claims at trial before a U.S. District Court. As another example, Jennifer was part of a team that negotiated a favorable settlement of an interference proceeding. Jennifer also has experience in appellate litigation, litigation before the International Trade Commission, and alternative dispute resolution. Jennifer enjoys translating her litigation experience into drafting and prosecuting robust patent applications, drafting durable opinions, negotiating and drafting favorable licenses, and providing meaningful client counseling.
In addition to having earned a B.S. in Biology, Jennifer studied and worked in laboratories for two academic years in a Ph.D. program, with emphasis on genetics, molecular biology, biochemistry, transgenics, immunology, and virology.
Jennifer is conversant in Lean/Six Sigma implementation, and she actively practices and promotes a culture of and drive towards continuous improvement.
Biotechnology / Pharmaceutical / Chemical: antibodies, including antibody engineering and therapies; immunotherapeutics, including chimeric antigen receptor (CAR) T cell engineering and therapies and T cell engineering and therapies; pharmaceutical formulations and delivery systems; CRISPR (clustered regularly interspaced short palindromic repeats) technology and alternatives thereto; enzymes; tissue regeneration; manipulation of cells in culture to manufacture products such as nutritional supplements; stem cell production; genetic engineering, including design and production of genetically engineered animals; and agricultural pesticides. Medical and Research Devices: vascular balloon catheters; ventilation therapy; spinal alignment; and microarrays and platform devices for biomedical, chemical, and pharmaceutical molecular research and diagnostics.
Medical Devices: vascular balloon catheters; ventilation therapy; spinal alignment; and microarrays and platform devices for biomedical, chemical, and pharmaceutical molecular research and diagnostics.
- IPWatchdog Life Sciences MastersTM 2023; Session Speaker for “The CRISPR Patent Wars: Implication for Human Medical Use”; October 17, 2023
- King and T. Herbert, “Seagate and Opinions of Counsel: Still A Sound Business Practice,” Intellectual Asset Management Magazine: Patents in the USA 2008: 40-43.
- Georgetown University Law Center, J.D., cum laude, 1999
- The George Washington University, B.S. Biology, magna cum laude, 1994
- District of Columbia, 1999
- United States Patent and Trademark Office, 2000
- United States District Court, District of Columbia
- United States Court of Appeals for the Federal Circuit